OxyTrack by Stratagen Bio

Stratagen Bio is developing a novel class of sensors that provide quantitative and direct measurements of tissue oxygen. Our sensor will enable more personalized and effective treatments for patients in a wide range of applications including oncology, wound healing, and tissue transplantation. This sensor is currently being evaluated in a pilot clinical trial at Brigham and Women’s Hospital for patients undergoing radiation therapy for cervical cancer. Identifying a low oxygen tumor, which is known to be more resistant to treatment, can help clinicians choose the best treatment and improve outcomes for each patient.